MiSight contact lenses
DeviceContact lens for myopia management.
NCT Number: NCT05955638
The purpose of the study is to quantify the effectiveness of Coopervision MiSight contact lenses in slowing the rate of myopia progression in university students.
Interested in participating?
Request Info18 year–21 year
All sexes
Interventional
Not applicable
University of Bradford, Bradford, West Yorkshire, United Kingdom
MiSight contact lenses have been shown to be a safe and effective way of managing myopia progression in children aged 8-12 years. However, myopic progression is not limited to children of this age group and MiSight lenses have also been shown to be effective in older children aged 11-16 years. There is evidence that progression also occurs in university students. The researchers are therefore investigating the effectiveness of this intervention in a group of UK-based University students.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Contact lens for myopia management.
Single vision contact lens as control
Time frame: Baseline, 24 months
Time frame: Baseline, 24 months
University of Bradford
Other
Acronym: MoMUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06221592
Eye Diseases, Myopia
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07264361
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial DetailsNCT03818880
Eye Diseases, Myopia
Waterloo, Ontario, Canada
View Trial DetailsNCT06563700
Eye Diseases, Myopia
Shanghai, China
View Trial Details